NBC News reports on a prescription drug, Gleevec, that enables some leukemia patients to live for 10 years or longer.
The once-a-day pill turned chronic myelogenous leukemia, or CML, from a certain death sentence into a manageable disease. Now data shows it's helped 83 percent of patients live 10 years or longer.Now we need one of those for each of the major cancers.
And some may be able to stop taking the pills altogether, even though they are not cured, the original team of researchers reported in the New England Journal of Medicine Thursday.
